- Condition: Acromegaly
Interventions: Drug: Pegvisomant; Drug: Somatostatin Receptor Ligand (SRL)
Sponsors: Cedars-Sinai Medical Center; Cedars-Sinai Medical Center
Recruiting - verified February 2012 - Condition: Acromegaly
Interventions: Drug: Pasireotide (SOM230); Drug: octreotide LAR 30mg or lanreotide ATG 120mg
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified November 2011 - Condition: Carcinoid Syndrome
Interventions: Drug: Somatuline Depot (lanreotide); Drug: placebo
Sponsors: Ipsen; Ipsen
Recruiting - verified April 2012 - Condition: Acromegaly
Intervention:
Sponsors: Ipsen; Ipsen
Recruiting - verified April 2012
 |
Angiopeptin Clinical Trials |
